Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on diabetes mellitus.

Murray Korc1

  • 1Division of Endocrinology, Department of Medicine, Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Hanover, NH 03756, USA. murray.korc@dartmouth.edu

Disease Markers
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why immunotherapy fails in immune-cold tumors: A systems framework from immune baseline to designable immune remodeling.

Cancer letters·2026
Same author

Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic Cancer.

Cancer research·2025
Same author

Improved survival in pancreatic ductal adenocarcinoma: Exciting promise of multimodal management strategies.

Cancer letters·2025
Same author

Bidirectional relationship between acute pancreatitis and pancreatic cancer.

Current opinion in gastroenterology·2024
Same author

Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Pancreas·2022
Same journal

RETRACTION: Pyrrosia petiolosa Extract Ameliorates Ethylene Glycol-Induced Urolithiasis in Rats by Inhibiting Oxidative Stress and Inflammatory Response.

Disease markers·2026
Same journal

Correction to "Estrogen Protects against Renal Ischemia-Reperfusion Injury by Regulating Th17/Treg Cell Immune Balance".

Disease markers·2026
Same journal

RETRACTION: miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.

Disease markers·2026
Same journal

RETRACTION: Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.

Disease markers·2026
Same journal

RETRACTION: Kartogenin Induced Adipose-Derived Stem Cell Exosomes Enhance the Chondrogenic Differentiation Ability of Adipose-Derived Stem Cells.

Disease markers·2026
Same journal

Correction to "KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells".

Disease markers·2026
See all related articles

Diabetes mellitus involves type 1 (autoimmune beta cell loss) and type 2 (insulin resistance). Proteomics offers new insights into the molecular defects underlying both diabetes types.

Area of Science:

  • Endocrinology
  • Immunology
  • Metabolic research

Background:

  • Diabetes mellitus is a complex, multi-system disorder with two primary forms: type 1 (autoimmune) and type 2 (insulin resistance).
  • Type 1 diabetes is characterized by the destruction of pancreatic beta cells, potentially involving immune cells and surrounding Schwann cells.
  • Type 2 diabetes arises from various factors, including impaired insulin signaling, inflammatory cytokines from adipose tissue, and mitochondrial dysfunction affecting glucose metabolism.

Purpose of the Study:

  • To elucidate the underlying molecular mechanisms of type 1 and type 2 diabetes.
  • To highlight the role of emerging proteomic technologies in understanding diabetes pathophysiology.

Main Methods:

  • Review and synthesis of current research on diabetes mellitus.

Related Experiment Videos

  • Application of proteome-based technologies for investigating cellular and molecular defects.

    • Main Results:

    • Identification of T-cell and cytokine-mediated destruction of beta cells in type 1 diabetes.
    • Characterization of diverse etiological factors in type 2 diabetes, including post-receptor insulin signaling defects, adipocyte-derived cytokines, and mitochondrial issues.
    • Demonstration of proteomic approaches revealing novel insights into these defects.

    Conclusions:

    • Proteome-based technologies are crucial for advancing our understanding of the complex molecular defects in both type 1 and type 2 diabetes.
    • Further research utilizing these advanced techniques will likely lead to improved diagnostic and therapeutic strategies for diabetes mellitus.